Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aptevo Therapeutics Inc. (APVO) had Stock-Based Compensation of $0.12M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.36M |
|
-- |
|
-- |
|
$6.44M |
|
$-6.44M |
|
$0.09M |
|
$-6.36M |
|
$-6.36M |
|
$-6.36M |
|
$-6.36M |
|
$-6.36M |
|
$-6.36M |
|
$-6.44M |
|
$-6.41M |
|
1.20M |
|
1.20M |
|
$-5.31 |
|
$-5.31 |
|
| Balance Sheet Financials | |
$10.80M |
|
$0.24M |
|
$3.72M |
|
$14.52M |
|
$5.19M |
|
-- |
|
$3.29M |
|
$8.48M |
|
$6.04M |
|
$6.04M |
|
$6.04M |
|
1.42M |
|
| Cash Flow Statement Financials | |
$-13.42M |
|
-- |
|
$1.60M |
|
$21.62M |
|
$9.80M |
|
$-11.82M |
|
|
Stock-Based Compensation |
$0.12M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-105.21% |
|
-105.21% |
|
-43.78% |
|
-105.21% |
|
$4.26 |
|
$-11.22 |
|
$-11.22 |
|